|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.110 HKD | +3.44% |
|
+1.38% | -3.80% |
| 07-07 | Weight-loss drug developers line up to tap lucrative market as competition heats up | RE |
| 07-07 | CSPC Pharma Begins Phase II Trial of Mixed Hyperlipidaemia Drug | MT |
| Market Cap | 92.72B 11.83B 10.37B 9.53B 8.83B 16.74B 1,128B 17.02B 114B 44.79B 557B 44.4B 43.44B 1,912B | P/E 2026 * |
11.2x | P/E 2027 * | 13.1x |
|---|---|---|---|---|---|
| Enterprise Value | 81.86B 10.44B 9.15B 8.42B 7.79B 14.78B 996B 15.03B 101B 39.55B 491B 39.2B 38.35B 1,688B | EV / Sales 2026 * |
2.29x | EV / Sales 2027 * | 2.25x |
| Free-Float |
67.42% | Yield 2026 * |
4.48% | Yield 2027 * | 4.54% |
| 1 day | +3.44% | ||
| 1 week | +1.38% | ||
| Current month | +16.36% | ||
| 1 month | +11.71% | ||
| 3 months | -12.42% | ||
| 6 months | -11.66% | ||
| Current year | -3.80% |
| 1 week | 7.64 |  | 8.58 |
| 1 month | 6.53 | | 8.58 |
| Current year | 6.53 | | 10.96 |
| 1 year | 6.53 | | 11.63 |
| 3 years | 4.27 | | 11.63 |
| 5 years | 4.27 | | 11.9 |
| 10 years | 3.47 | | 13.93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lei Cai
CEO | Chief Executive Officer | 46 | 19/12/2025 |
Qing Jie Wei
COO | Chief Operating Officer | 56 | 19/12/2025 |
Zhi Yong Qu
PRN | Corporate Officer/Principal | 44 | 01/07/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Dong Chen Cai
CHM | Chairman | 72 | 26/08/2011 |
Zhen Guo Wang
BRD | Director/Board Member | 56 | 20/01/2012 |
Bo Wang
BRD | Director/Board Member | 66 | 21/12/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-23 | Other | Chief Operating Officer | -1,400,000 | 0.0122% | ||
| 06-23 | Other | Director | -700,000 | 0.0061% | ||
| 06-22 | Other | Chairman | 14,650,000 | 0.1271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.44% | +1.38% | +0.75% | +24.39% | 11.83B | |
| -2.33% | -2.09% | +50.33% | +162.29% | 1,060B | |
| -0.82% | -2.30% | +62.97% | +61.11% | 619B | |
| -0.73% | -4.98% | +27.22% | +84.46% | 438B | |
| +0.33% | -1.17% | +27.98% | +26.90% | 333B | |
| -0.02% | -2.85% | +25.27% | +44.88% | 282B | |
| -3.89% | -11.22% | +20.78% | +26.07% | 267B | |
| +0.66% | -1.42% | -29.26% | -39.30% | 218B | |
| -0.06% | -2.88% | +20.98% | +61.70% | 196B | |
| -3.72% | -1.10% | +13.35% | +71.53% | 161B | |
| Average | -0.71% | -2.78% | +22.04% | +52.40% | 358.57B | |
| Weighted average by Cap. | -1.30% | -2.94% | +35.17% | +81.08% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 35.68B 4.55B 3.99B 3.67B 3.4B 6.44B 434B 6.55B 43.91B 17.23B 214B 17.09B 16.71B 736B | 35.2B 4.49B 3.93B 3.62B 3.35B 6.35B 428B 6.46B 43.32B 17B 211B 16.85B 16.49B 726B |
| Net income | 7.94B 1.01B 887M 816M 756M 1.43B 96.56B 1.46B 9.77B 3.83B 47.65B 3.8B 3.72B 164B | 6.92B 882M 773M 711M 659M 1.25B 84.15B 1.27B 8.51B 3.34B 41.52B 3.31B 3.24B 143B |
| Net Debt | -10.86B -1.39B -1.21B -1.12B -1.03B -1.96B -132B -1.99B -13.37B -5.25B -65.21B -5.2B -5.09B -224B | -13.44B -1.71B -1.5B -1.38B -1.28B -2.43B -163B -2.47B -16.54B -6.49B -80.67B -6.44B -6.3B -277B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 10/07/26 | HK$8.110 | +3.44% | 151,885,646 |
| 09/07/26 | HK$7.840 | 0.00% | 110,379,063 |
| 08/07/26 | HK$7.840 | -0.38% | 89,630,124 |
| 07/07/26 | HK$7.870 | -4.37% | 89,651,208 |
| 06/07/26 | HK$8.230 | +2.88% | 171,801,547 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 1093 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
